Cas:370-50-3 flucofuron manufacturer & supplier

Chemical Name:flucofuron

CAS.NO:370-50-3

Synonyms:N,N’-bis[4-chloro-3-(trifluoromethyl)phenyl]urea;1,3-Bis[4-chloro-3-(trifluoromethyl)phenyl]urea;flucofuron;N,N’-Bis[4-chloro-3-(trifluoromethyl)phenyl]carbamimidic acid;N,N’-Bis[4-chloro-3-(trifluoromethyl)phenyl]urea;tcmdc-137559;1,3-bis(4-chloro-α,α,α-trifluoro-m-tolyl)urea;1,3-Bis(4-chloro-a,a,a-trifluoro-m-tolyl)urea;Methanol, 1-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-1-[[4-chloro-3-(trifluoromethyl)phenyl]imino]-, (E)-;Urea, N,N’-bis[4-chloro-3-(trifluoromethyl)phenyl]-;1,3-Bis[4-chloro-3-(trifluoromethyl)phenyl]urea;EINECS 206-728-7;Sorafenib Impurity I

Molecular Formula:C₁₅H₈Cl₂F₆N₂O

Molecular Weight:417.133

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:339.9±42.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.564

PSA:41.13000

Exact Mass:415.991791

LogP:7.82

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N,N’-bis[4-chloro-3-(trifluoromethyl)phenyl]urea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sorafenib Impurity I physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Urea, N,N’-bis[4-chloro-3-(trifluoromethyl)phenyl]- Use and application,EINECS 206-728-7 technical grade,usp/ep/jp grade.

Related News: He said it is “normal” for scientists and clinicians to discuss and debate data from experiments and clinical trials, but added those discussions have taken a turn “outside the boundaries of legitimate scientific deliberation.” 2-acetylbicyclo(2.2.1)hepta-2,5-diene manufacturers According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3,4-dimethylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate suppliers Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. samarium(III) hexacyanocobaltate(III) hydrate vendor & factory The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production.,According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug.